Jamaica’s ‘Good Ganja Sense’ Campaign Aims to Correct Misconceptions About Cannabis
by Bethan Rose
by Gary Miller
After a strong 2021, all signs are pointing to an even bigger year for the cannabis industry in 2022. According to a report from Marijuana Business Daily, U.S. legal cannabis sales are predicted to surpass $30 billion in 2022. The number may seem high, but there are plenty of reasons experts believe the prediction will be spot on.
For starters, American support of cannabis, already at a record high, will only increase as cannabis becomes more accessible. A Gallup poll from 2021 revealed that around 68% of Americans were in support of cannabis legalization.
The poll highlighted how accessibility and education about cannabis have begun to peel away old stigmas surrounding the plant. With more states entering the legal market in 2022, experts expect cannabis to become even more socially acceptable.
Accessibility isn’t just great for consumers either. Another large part of experts’ optimistic forecast for cannabis is an increase in research about the plant. Before 1999, there were fewer than 5,000 published studies on cannabis. In 2020 alone the number of cannabis studies was over 3,500.
2022 is looking to be an even bigger year for cannabis research, featuring exciting studies like one on non-THC and CBD cannabinoids by Colorado State University. Studies like this one not only help to further destigmatize cannabis, but they can also lead to the creation of new and more effective cannabis products.
Between growing cannabis accessibility and education, there is no limit to the heights this skyrocketing industry may reach this year.
The flowering buds of the cannabis plant have always been the star of the show due to their high concentration of cannabinoids like THC and CBD that create effects for consumers. But what many don’t know is that other parts of the plant—specifically the trim removed after harvesting—can be used for a variety of purposes….
Many states across the U.S. have legalized cannabis for medical and retail consumption. The regulations governing these industries primarily focus on the products’ content of the two most prominent cannabinoids found in the cannabis plant, cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). But in recent months, a new cannabinoid known as delta-8-tetrahydrocannabinol (delta-8 THC) has entered the…
Humans were experimenting with cannabis use for medical and recreational purposes before we traveled the Silk Road or even wrote history down (1). Archeologists discovered pounds of dried cannabis in ancient Chinese shaman bags, and cannabis was burned as an incense offering at the Holy of Holies altar in a Judahite shrine in Tel Arad,…
The word ‘endocannabinoid’ seems to belong to cannabis at first glance. However, some may be surprised to find out that all humans have an endocannabinoid system and professionals are still trying to completely understand the endocannabinoid system (ECS). Researchers have discovered the ECS by trying to understand how cannabinoids play a role in the body….
Since Nov. 8, prime brokerage clients affiliated with JPMorgan Chase & Co. have been unable to purchase some cannabis-associated securities. The news, which was officially announced in a letter, confirmed that the bank would no longer be granting new acquisitions or “short” positions in cannabis-focused businesses. However, the letter also noted that clients who already…
Cookies are one of the best baked goods. They are easy to hold in one hand. They’re individual-sized, so you don’t have…
One of the most significant goals of many legalization efforts is to draw people away from the illicit markets. While the illicit…
Louisiana’s medical cannabis expansion has gotten mixed reviews, Mississippi’s proposed legalization legislation may be too good to be true, and Colorado cemented…
